Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

BACKGROUND AND PURPOSE: Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Stroke
Autors principals: Lee, Eun-Jae, Kwon, Sun U., Park, Jong-Ho, Kim, Yong-Jae, Hong, Keun-Sik, Yu, Sungwook, Hwang, Yang-Ha, Lee, Ji Sung, Lee, Juneyoung, Rha, Joung-Ho, Heo, Sung Hyuk, Ahn, Sung Hwan, Seo, Woo-Keun, Park, Jong-Moo, Lee, Ju-Hun, Kwon, Jee-Hyun, Sohn, Sung-Il, Jung, Jin-Man, Kim, Hahn Young, Kim, Eung-Gyu, Kim, Sung Hun, Cha, Jae-Kwan, Park, Man-Seok, Nam, Hyo Suk, Kang, Dong-Wha
Format: Artigo
Idioma:Inglês
Publicat: Korean Stroke Society 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7005357/
https://ncbi.nlm.nih.gov/pubmed/32027796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5853/jos.2019.02551
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars